Fig. 1From: Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysisForest plot of the incidence of myocardial reperfusion: intracoronary vs. intravenous glycoprotein IIb/IIIa inhibitors (a) Thrombolysis in myocardial infarction (TIMI) grade 3 flow, (b) myocardial blush grade 2/3, (c) TIMI myocardial perfusion grade 3 (d) corrected TIMI frame count, and (e) complete ST-segment resolutionBack to article page